Virpax Pharmaceuticals, Inc. (VRPX)
NASDAQ: VRPX · Real-Time Price · USD
0.617
-0.043 (-6.56%)
At close: Nov 20, 2024, 4:00 PM
0.604
-0.013 (-2.09%)
After-hours: Nov 20, 2024, 7:58 PM EST
Virpax Pharmaceuticals Employees
Virpax Pharmaceuticals had 7 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,891,264
Market Cap
3.02M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | 0 | - |
| Dec 31, 2022 | 7 | 0 | - |
| Dec 31, 2021 | 7 | 5 | 250.00% |
| Dec 31, 2020 | 2 | 0 | - |
| Dec 31, 2019 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Aditxt | 47 |
| Processa Pharmaceuticals | 13 |
| Bio-Path Holdings | 10 |
| Palisade Bio | 9 |
| Enveric Biosciences | 7 |
| GlucoTrack | 6 |
| Titan Pharmaceuticals | 4 |
| Quoin Pharmaceuticals | 4 |
VRPX News
- 2 days ago - Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering - GlobeNewsWire
- 5 days ago - Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 7 days ago - Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 6 weeks ago - This FactSet Research Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday - Benzinga
- 3 months ago - Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments - Business Wire
- 3 months ago - Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15 - Business Wire
- 4 months ago - Virpax Regains Compliance with Nasdaq Minimum Bid Price - Business Wire
- 4 months ago - Crude Oil Gains Over 1%; Virpax Pharmaceuticals Shares Spike Higher - Benzinga